|
🐜
|
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
61 auth.
E. Rondeau,
M. Scully,
G. Ariceta,
T. Barbour,
S. Cataland,
N. Heyne,
Y. Miyakawa,
S. Ortiz,
E. Swenson,
M. Vallée,
S. Yoon,
D. Kavanagh,
H. Haller,
S. Babu,
N. Broeders,
...
N. Lietar,
Fiona C. Brown,
P. Campbell,
P. Chowdhury,
T. Kasimatis,
L. Cirami,
L. Caroti,
Guilia Antognoli,
Yahsou Delmas,
V. Dobronravov,
Anja Gaeckler,
C. Garrouste,
G. Greenwood,
S. Griffin,
Chiu-Ching Huang,
I. Chen,
Susan Huang,
Jin Seok Kim,
G. La Manna,
G. Comai,
M. Cappuccilli,
M. Le Quintrec,
Guillaume Jeantet,
Iino Fumie,
Y. Luque,
J. Menne,
J. Morelle,
É. Goffin,
Anja Muhlfeld,
S. Nagaraj,
G. Arepally,
D. Oh,
M. Okumi,
Manuel Praga Terente,
E. Gutiérrez,
P. Rodríguez,
F. Provôt,
U. Schönermarck,
M. Fischereder,
N. Terrada,
B. Seitz-Polski,
G. Favre,
Sonia Boyer-Suavet,
M. Vinogradova,
T. Kirsanova,
E. Wong
|
7 |
2020 |
7
🐜
|
|
🐜
|
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.
12 auth.
C. Pozzi,
S. Andrulli,
A. Pani,
P. Scaini,
L. Del Vecchio,
G. Fogazzi,
...
B. Vogt,
Vincenzo De Cristofaro,
L. Allegri,
L. Cirami,
A. Procaccini,
F. Locatelli
|
7 |
2010 |
7
🐜
|
|
🐜
|
Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults
56 auth.
T. Barbour,
M. Scully,
G. Ariceta,
S. Cataland,
Katherine Garlo,
N. Heyne,
Y. Luque,
J. Menne,
Y. Miyakawa,
S. Yoon,
D. Kavanagh,
S. Babu,
N. Broeders,
N. Lietar,
F. Brown,
...
P. Campbell,
J. Campistol,
P. Chowdhury,
T. Kasimatis,
L. Cirami,
L. Caroti,
Guilia Antognoli,
Yahsou Delmas,
V. Dobronravov,
Anja Gaeckler,
C. Garrouste,
G. Greenwood,
S. Griffin,
Chiu-Ching Huang,
I. Chen,
Susan Huang,
Jin Seok Kim,
G. La Manna,
M. Le Quintrec,
Guillaume Jeantet,
Iino Fumie,
E. Rondeau,
H. Haller,
J. Morelle,
É. Goffin,
Anja Muhlfeld,
S. Nagaraj,
G. Arepally,
D. Oh,
M. Okumi,
Manuel Praga Terente,
F. Provôt,
U. Schönermarck,
M. Fischereder,
N. Terrada,
B. Seitz-Polski,
G. Favre,
Sonia Boyer-Suavet,
M. Vinogradova,
T. Kirsanova,
E. Wong
|
5 |
2021 |
5
🐜
|
|
🐜
|
Association between chronic kidney disease and periodontitis. a systematic review and metanalysis.
7 auth.
L. Serni,
L. Caroti,
L. Barbato,
M. Nieri,
S. Serni,
L. Cirami,
...
Cairo Francesco
|
5 |
2021 |
5
🐜
|
|
🐜
|
Multiple immune disorders in unrecognized celiac disease: a case report.
7 auth.
G. la Villa,
P. Pantaleo,
R. Tarquini,
L. Cirami,
F. Perfetto,
F. Mancuso,
...
G. Laffi
|
4 |
2003 |
4
🐜
|
|
🐢
|
Broad spectrum of interferon-related nephropathies-glomerulonephritis, systemic lupus erythematosus-like syndrome and thrombotic microangiopathy: A case report and review of literature
I. Gianassi,
Marco Allinovi,
L. Caroti,
L. Cirami
|
4 |
2019 |
4
🐢
|
|
🐜
|
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult
33 auth.
Martina Tedesco,
Federica Mescia,
I. Pisani,
Marco Allinovi,
G. Casazza,
L. Del Vecchio,
M. Santostefano,
L. Cirillo,
F. Ferrario,
C. Esposito,
P. Esposito,
D. Santoro,
R. Lazzarin,
G. M. Rossi,
E. Fiaccadori,
...
A. Ferrantelli,
R. Sinico,
M. Cozzolino,
M. Gallieni,
S. Affatato,
L. Caroti,
E. Mancini,
L. Semeraro,
Rossella Siligato,
Matthias Arnaldo Cassia,
P. Napodano,
M. Calatroni,
C. Distratis,
A. Campo,
L. Cirami,
F. Scolari,
A. Vaglio,
F. Alberici
|
4 |
2022 |
4
🐜
|
|
🐬
|
Exercise Prescription in Renal Transplant Recipients: From Sports Medicine Toward Multidisciplinary Aspects: A Pilot Study
Goffredo Orlandi,
F. Sofi,
L. Moscarelli,
L. Cirami,
S. Mancini,
L. Stefani
|
3 |
2020 |
3
🐬
|
